Podcasts

Viral Hepatitis – What’s Changing?

Join Dr. Paul Kwo, from Stanford Medicine, and Dr. Tatyana Kushner, from Weill Cornell Medicine, for an insightful discussion on the evolving landscape of viral hepatitis, with a focus on hepatitis B, C, and delta hepatitis. This expert-led conversation explores the path toward hepatitis elimination by 2030, highlighting the latest advances in functional cure strategies for hepatitis B—including antisense oligonucleotides, capsid inhibitors, and immune modulators—and how they may redefine long-term disease management. The session also addresses the challenges of expanding hepatitis C treatment access to underserved and high-risk populations, the potential of long-acting injectables, and the need for simplified, rapid test-and-treat models. The dialogue concludes with a thoughtful analysis of delta hepatitis screening, global treatment guidelines, and the realistic timeline for achieving a functional cure for hepatitis B. Whether you’re a hepatologist, infectious disease specialist, or public health professional, this conversation offers critical insights into the next era of viral hepatitis care and innovation.